BELLUS Health Inc.

LSE:0A4U Stock Report

Market Cap: CA$2.5b

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

BELLUS Health Management

Management criteria checks 2/4

BELLUS Health's CEO is Roberto Bellini, appointed in Jan 2010, he has a tenure of 13.42 years. His total yearly compensation is $5.88M , comprised of 6.6% salary and 93.4% bonuses, including company stock and options. He directly owns 1.42% of the company’s shares, worth CA$34.92M. The average tenure of the management team and the board of directors is 2.5 years and 13.5 years respectively.

Key information

Roberto Bellini

Chief executive officer

US$5.9m

Total compensation

CEO salary percentage6.6%
CEO tenure13.4yrs
CEO ownership1.4%
Management average tenure2.5yrs
Board average tenure13.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Roberto Bellini's remuneration changed compared to BELLUS Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$87m

Dec 31 2022US$6mUS$389k

-US$76m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$71m

Mar 31 2022n/an/a

-US$70m

Dec 31 2021US$2mUS$327k

-US$71m

Sep 30 2021n/an/a

-US$64m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$37m

Dec 31 2020US$3mUS$299k

-US$32m

Sep 30 2020n/an/a

-US$34m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$33m

Dec 31 2019US$2mUS$280k

-US$26m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$14m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$568kUS$206k

-US$7m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$4m

Dec 31 2017US$622kUS$253k

-US$1m

Sep 30 2017n/an/a

-US$613k

Jun 30 2017n/an/a

US$234k

Mar 31 2017n/an/a

-US$219k

Dec 31 2016US$288kUS$266k

-US$2m

Compensation vs Market: Roberto's total compensation ($USD5.88M) is above average for companies of similar size in the UK market ($USD2.05M).

Compensation vs Earnings: Roberto's compensation has increased whilst the company is unprofitable.

CEO

Roberto Bellini (43 yo)

13.4yrs

Tenure

US$5,884,787

Compensation

Mr. Roberto Francesco Bellini has been the Chief Executive Officer and President of BELLUS Health Inc, since January 1, 2010. Mr. Bellini served as an Executive Vice President of Picchio Pharma Inc. until...

Leadership Team

NamePositionTenureCompensationOwnership
Roberto Bellini
President13.4yrsUS$5.88m1.42%
CA$ 34.9m
Ramzi Benamar
Chief Financial Officer2.5yrsUS$1.67mno data
Andreas Orfanos
Chief Operating Officer1.2yrsUS$2.51mno data
Denis Garceau
Chief Scientific Officer2yrsUS$1.52m0.25%
CA$ 6.1m
Catherine Bonuccelli
Chief Medical Officer3.8yrsUS$1.76mno data
Daniel Matthews
Director of Investor Relations & Communicationsno datano datano data
Tony Matzouranis
Chief Business Officer2yrsUS$626.31k0.13%
CA$ 3.1m
Sebastien Roy
Corporate Secretary12.3yrsno datano data

2.5yrs

Average Tenure

50yo

Average Age

Experienced Management: 0A4U's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Roberto Bellini
President14.4yrsUS$5.88m1.42%
CA$ 34.9m
Francesco Bellini
Chairman of the Board21.4yrsUS$752.59k0.35%
CA$ 8.5m
Franklin Berger
Independent Director13.1yrsUS$367.33k0.55%
CA$ 13.5m
Joseph Rus
Independent Director14yrsUS$341.85k0.047%
CA$ 1.2m
Clarissa Desjardins
Independent Director5.8yrsUS$271.94k0.082%
CA$ 2.0m
Youssef Bennani
Independent Director6.1yrsUS$286.17k0.13%
CA$ 3.1m
Pierre Larochelle
Independent Lead Director14yrsUS$550.99k0.18%
CA$ 4.5m
William Mezzanotte
Independent Director2.3yrsUS$253.58kno data

13.5yrs

Average Tenure

63yo

Average Age

Experienced Board: 0A4U's board of directors are seasoned and experienced ( 13.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/28 06:06
End of Day Share Price 2023/06/21 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BELLUS Health Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Justin ZelinBTIG
Pooya HemamiEdison Investment Research